Carlsson, Carlsson, Jacobson)
Patients should be aware of red flags requiring medical attention
Quieting "Food Noise": How GLP-1s and Mindfulness Rewire the Default Mode Network (DMN) and Reward Circuits
Initially approved for glycemic control in type 2 diabetes mellitus, their clinical application has expanded into obesity management, cardiovascular risk reduction, and metabolic syndrome modulation
For diarrhoea related to medication, K52.9 (Noninfective gastroenteritis and colitis, unspecified) or R19.7 (Diarrhoea, unspecified) may be appropriate depending on clinical context
Gastrointestinal issues are usually strongest in first-time users, or when people step up to a larger dosage, but they usually dissipate over time